Security key
254604101
Disc Medicine, Inc. - Common Stock, $0.0001 par value per share (IRON)
CUSIP: 254604101
Q2 2024 13F Holders as of 30 Jun 2024
- Security type / class
- Equity / Common Stock, $0.0001 par value per share
- Total 13F shares
- 27,576,793
- Total 13F value
- $1,242,993,864
- Share change
- +5,317,837
- Put/Call ratio
- 34%
- SEC-reported price per share
- $45.07
- Number of holders
- 119
- Value change
- +$212,594,407
- Number of buys
- 81
- Number of sells
- 64
- Shares outstanding
- 37,778,373
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2024
Institutions
119
Top holders
10
IRON full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2024
Previous quarter: Q1 2024
Disc Medicine, Inc. SEC filings
Disc Medicine, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 254604101
Recent filing periods:
Ownership snapshot
Top reported holders of IRON - Disc Medicine, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Paradigm Biocapital Advis...
Disclosed value leader
Paradigm Biocapital Advis...
Comparable rows
15/15
Latest evidence
31 Mar 2024
13F
Lead comparable stake: 6.3%
Showing 1-6 of 15 holder rows.
Quick read
Paradigm Biocapital Advisors LP leads the comparable SEC ownership view at 6.3%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Paradigm Biocapital Advisors LP's linked filing trail.
Comparable ownership
Top 5
Paradigm Biocapital Advisors LP
6.3%
Atlas Venture Life Science Adviso...
6.1%
ORBIMED ADVISORS LLC
4.5%
Bain Capital Life Sciences Invest...
3.5%
STATE STREET CORP
2.9%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Paradigm Biocapital Advisors LP |
13F
Company
|
6.3%
|
$148,795,299
2,389,902 shares
|
— | 31 Mar 2024 |
| Atlas Venture Life Science Advisors, LLC |
13F
Company
|
6.1%
|
$142,403,127
2,287,233 shares
|
— | 31 Mar 2024 |
| ORBIMED ADVISORS LLC |
13F
Company
|
4.5%
|
$105,981,276
1,702,237 shares
|
— | 31 Mar 2024 |
| Bain Capital Life Sciences Investors, LLC |
13F
Company
|
3.5%
|
$82,009,681
1,317,213 shares
|
— | 31 Mar 2024 |
| STATE STREET CORP |
13F
Company
|
2.9%
|
$67,938,797
1,091,211 shares
|
— | 31 Mar 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
Company
|
2.5%
|
$58,788,000
944,213 shares
|
— | 31 Mar 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
119
Shares
27,576,793
Rows available
119
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
125
Q2 2024 holders
119
Holder diff
-6
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q2 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend